平均血小板容积与青年ST段抬高型心肌梗死的关系被引量：1

The relationship between mean platelet volume and acute ST-segment elevation myocardial infarction in young patients

下载PDF

导出

摘要目的研究平均血小板容积（MPV）与青年ST段抬高型心肌梗死（STEMI）的关系.方法回顾分析2011-2014年在郑州大学附属洛阳中心医院接受急诊PCI的年龄≤45岁的青年STEMI患者79例,同期冠脉造影正常的青年患者45例作为对照组.两组参数变量比较采用t检验,分类资料比较采用卡方检验.对于青年心梗与MPV及其他参数的相关性采用多元Logistic回归方法,P＜0.05具有统计学意义.结果 STEMI组患者的MPV高于对照组[（8.5±1.3）fl比（7.7±0.8）fl,P＜0.05],两组血小板数量未见明显差异[（236±35）×10^9比（249±43）×10^9,P＞0.05].多元Logistic回归分析发现,MPV为青年发生STEMI的独立危险因素（OR=1.512,P=0.001）.结论 MPV增高与青年STEMI的发生可能具有相关性. Objective To investigate the relationship between mean platelet volume and acute ST-seg- ment elevation myocardial infarction in young patients. Methods This study included 79 young patients （≤45 ages） who presented to our hospital with acute myocardial infarction and 45 young patients with normal coronary angiography as a control group. Results Compared with control group, STEMI group had a significantly higher value of MPV [（8.5±1.3）fl vs （7.7±0.8）fl, P〈0.05]. After multivariate analysis, high levels of MPV were inde- pendent predictors of STEMI in young patients（OR=1.512, P=0.001 ）. Conclusion High levels of MPV were as- sociated with STEMI in young patients.

作者谷云飞金军薛书峰陈剑锋贺惠娟段卡丹刘磊王静邱梅红

机构地区郑州大学附属洛阳中心医院心内科洛阳市心脑血管病研究所

出处《中国心血管病研究》 CAS 2015年第5期436-438,共3页 Chinese Journal of Cardiovascular Research

关键词平均血小板容积青年 ST段抬高型心肌梗死 Mean platelet volume Young patients Acute ST-segment elevation myocardial infarcion

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献3

1无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量：1978
2李佳蓓,黄岚.血小板在动脉粥样硬化血栓形成中的作用[J].中华心血管病杂志,2014,42(2):175-177. 被引量：18
3谷云飞,金军,张守彦,薛书峰,陈剑锋,贺惠娟,段卡丹,常学伟.红细胞分布宽度与青年ST段抬高型心肌梗死的关系[J].中国心血管病研究,2014,12(8):686-688. 被引量：10

二级参考文献31

1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量：43
2Bhatt DL,Steg PG,Ohman EM,et al.International prevalence,recognition,and treatment of cardiovascular risk factors in outpatients with atherothrombosis[J].JAMA,2006,295:180-189.
3Viles-Gonzalez JF,Fuster V,Badimon JJ.Atherothrombosis:a widespread disease with unpredictable and life-threatening consequences[J].Eur Heart J,2004,25:1197-1207.
4Wu Y,Ahmad SS,Zhou J,et al.The disulfide isomerase ERp57 mediates platelet aggregation,hemostasis,and thrombosis[J].Blood,2012,119:1737-1746.
5Broos K,Trekels M,Jose RA,et al.Identification of a small molecule that modulates platelet glycoprotein Ⅰb-von Willebrand factor interaction[J].J Biol Chem,2012,287:9461-9472.
6Auton M,Sowa KE,Behymer M,et al.N-terminal flanking region of A1 domain in yon Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress[J].J Biol Chem,2012,287:14579-14585.
7Kalli AC,Campbell ID,Sansom MS.Multiscale simulations suggest a mechanism for integrin inside-out activation[J].Proc Natl Acad Sci U S A,2011,108:11890-11895.
8Singh HS,Dangas GD,Guagliumi G,et al.Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMItrial)[J].Am J Cardiol,2012,110:940-947.
9O'Brien KA,Gartner TK,Hay N,et al.ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β[J].Arterioscler Thromb Vasc Biol,2012,32:2232-2240.
10Angiolillo DJ,Capodanno D,Goto S.Platelet thrombin receptor antagonism and atherothrombosis[J].Eur Heart J,2010,31:17-28.